Partial anterior cruciate ligament tears treated with intraligamentary plasma rich in growth factors

Table 1 Inclusion and exclusion criteria for the review

Inclusion criteria	Exclusion criteria
Acute ruptures of the anterior cruciate ligament	Patients who were not active before the ACL injury
Active players competing in national and international teams (Tegner 9-10)	Patients with Tegner < 9
Clinic knee instability	Patients without evidence of instability (pivot shift more than 5 mm difference)
Magnetic resonance imaging of anterior cruciate ligament rupture	Ligaments with both bundles intact
Positive drawer	Ligaments with injury to both bundles or where the remaining bundle was clearly insufficient
One of the bundles intact	Infectious diseases, tumors, collagen, soft tissue or blood
First surgical procedure on evaluated knee
Informed consent of the treatment

ACL: Anterior cruciate ligament.

Table 2 Epidemiological data

No.	Age	Tegner	RTP wk	KT-1000 pre	KT-1000 post	TTS wk
1	24	9	15	3	1	7
2	23	9	16	3	0	6
3	27	9	15	2	0	7
4	29	9	17	2	0	8
5	21	9	14	4	1	6
6	22	9	15	3	0	7
7	28	10	12	3	0	2
8	32	9	-	5	2	5
9	31	9	15	4	1	6
10	25	10	11	3	0	1
11	20	9	14	4	1	6
12	23	10	14	3	0	1
13	21	9	15	3	0	7
14	27	9	17	4	1	8
15	29	9	18	3	0	5
16	24	9	17	2	0	8
17	27	9	19	2	0	7
18	30	9	20	3	1	7
19	22	9	16	2	1	6

RTP: Return to play; TTS: Time to surgery; KT-1000: Difference between both knees.